| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 6YY8O697VF |
Pharmacology
| Primary Target | |
|---|---|
| 4-1BB |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, Large B-Cell, Diffuse | 3 | D016403 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Lymphoma, Follicular | 1 | D008224 | ClinicalTrials |
| Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
| Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
| Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
| Lymphoma, Follicular | 1 | D008224 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1417318-27-4 |
| ChEMBL | CHEMBL3707324 |
| FDA SRS | 6YY8O697VF |
| Guide to Pharmacology | 9244 |
CONTENTS